Applying Ethics and Integrity to Human Research

IntegReview reviews the following types of research: Phase I-IV drug/biomedical, medical device, social and behavioral, Investigator-sponsored, single and multiple investigator as well as research conducted in academic and hospital settings, expedited review for research that qualifies, expedited review of additional Investigators, research determined to be exempt, International research and Canadian investigators.

• Home
• About Us
  • Mission Statement
  • Core Values
  • IRB Statement of Compliance
  • Staff
  • Membership Roster
  • Professional Affiliations
  • Client Affirmations
  • Privacy & Confidentiality
  • FDA/OHRP IRB Registration
  • Key Management Personnel
• Resources
  • AAHRPP Accreditation
  • Canadian REB
  • Processes
  • FAQs
  • Upcoming Events
  • Meeting Calendars
  • IntegReview HIPAA Policy
  • Submission Deadlines
  • Translation Policy
  • Expedited Review Process
  • Definitions & Acronyms
• Employment Opps
• Contact Us
  • Subject Feedback
  • Client Survey
  • Employee Recognition
  • Email our Staff

• Forms
• Training Campus
• Principal Investigator
  • Responsibilities
  • Reporting Requirements
  • Training
  • Form FDA 1572
  • Regulation & Guidance Docs
• Sponsor/Project Mgr
  • Responsibilities
  • Reporting Requirements
  • Training
  • Regulation & Guidance Docs
• Research Participant
  • Questions/Comments
  • Helpful Links
  • Subject Feedback
• IntegReview Updates
• Services & Fees

IntegReview Ethical Review Board
3001 S. Lamar Blvd., Suite 210
Austin, TX 78704
Phone: 512-326-3001
Fax: 512-697-0085
Email:

Contact Us

IntegReview Ethical Review Board

3001 S. Lamar Blvd., Suite 210

Austin, TX 78704

Phone: 512-326-3001

Fax: 512-697-0085 (fax)

Email: integreview@integreview.com

IntegReview, Copyright © . All rights reserved. | Web site development by Enhanced Web Services / Austin Computing Solutions